Family planning: today and in the future.
This review covers the state of contraceptive development noting new entries in the clinic (mainly steroidal and different delivery methods) and novel leads for nonsteroidal female- and male-methods in the pipeline. The time taken to market and the absence of partnerships with industry are stressed as major factors for the slow progress in their development.
Harper
Michael J K
MJ
Department of Obstetrics and Gynecology, Eastern Virginia Medical School, 1911 N. Fort Meyer Drive, Suite 900, Arlington, VA 22209, USA. mjkharper@gmail.com
D003271:Contraceptive Agents, Female; D003272:Contraceptive Agents, Male; D004353:Drug Evaluation, Preclinical; D005193:Family Planning Services / Q000639:trends*; D005260:Female; D006801:Humans; D008297:Male; D057170:Translational Research, Biomedical
D003271:Contraceptive Agents, Female; D003272:Contraceptive Agents, Male